Founded 2022
Founders Rory Ryan, CEO Phil Haynes, CTO

PentaBind applies generative AI to design and optimize aptamers—synthetic binding molecules for therapeutic and diagnostic use. The approach accelerates discovery cycles and improves target specificity by modeling molecular interactions in silico, reducing development time.


Founders

Rory
Ryan

CEO

Rory is a third time founder. He cofounded ZiO Health, which he sold after leading it on product and operations for six years. With eight years of aptamer industry experience, he has first-hand customer experience of aptamer wet-labs. He graduated from the University of Leeds with a First Class in Engineering and a Distinction Master’s at Imperial College Business School.

Linkedin

Phil
Haynes

CTO

Phil has five years of drug discovery experience in aptamers and cancer therapeutic, and holds a PhD in Molecular Biophysics from UCL and Imperial College. He has worked with multiple research institutes and pharma companies, including AstraZeneca. He holds a First Class degree in Physics from the University of Exeter. 

Linkedin

Related

A&B Smart Materials

Biodegradable smart hydrogels for passive cooling.
CTO
Founded
2023

A51

Programmable RNA therapeutics platform.
Founded
2025

Accurx

Powering communications in the healthcare sector.
Founding CTO
Founded
2016

Ackcio

Mesh wireless monitoring for sensors.
Cofounder
Founded
2017

Adbrain

Cross-device identity for personalized marketing.
Cofounder
Cofounder

Affable

AI analytics for influencer campaigns.
Founded
2017